Cargando…
Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation
Edaravone (EDR) is a well-recognized lipophilic free radical scavenger for diseases including neurodegenerative disease, cardiovascular disease, and cancer. However, its oral use is restricted due to poor oral bioavailability (BA). The aim of present research was to enable its oral use by developing...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241028/ https://www.ncbi.nlm.nih.gov/pubmed/28633547 http://dx.doi.org/10.1080/10717544.2017.1337825 |